Owens, Gemma L.
Price, Marcus J.
Cheadle, Eleanor J.
Hawkins, Robert E.
Gilham, David E.
Edmondson, Richard J. http://orcid.org/0000-0003-2553-4423
Funding for this research was provided by:
Cancer Research UK
Article History
Received: 30 January 2018
Accepted: 17 July 2018
First Online: 23 July 2018
Compliance with ethical standards
:
: Robert Hawkins and David Gilham are co-founders and shareholders of Cellular Therapeutics Ltd. All other authors have no conflicts of interest to declare.
: Patient samples were collected through the Manchester University NHS Foundation Trust Biobank with ethical approval granted by the NHS National Research Ethics Service (NRES) Committee North West (approval number 14/NW/1260). All procedures performed in this study were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all study participants.